EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 4
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Regional News

Moderna CFO Meline steps down $42 million richer, passing reins to incoming finance chief Gomez

Coming out of retirement to work for Moderna as its chief financial officer was a sweet deal for David Meline. In fact, it will make him $42 million richer. T...
13 April 2022 Regional News companies | financial
Continue Reading →
Regional News

Using sumo ads, Moderna makes a heavy marketing push in Japan to rebuild trust in its COVID-19 vaccine

When some Moderna COVID-19 vaccine vials were found to be contaminated with metallic shards last year in Japan, the company suffered a reputation crisis in a country ...
23 March 2022 Regional News Asia | COVID-19
Continue Reading →
Regional News

Moderna seeks FDA nod for COVID vaccine in children under 6, starts delayed filing for older kids

Moderna has new data backing the use of its COVID-19 vaccine Spikevax at a low dose in the youngest children under the age of 6, and it’s moving forward with global r...
23 March 2022 Regional News children | COVID
Continue Reading →
Regional News

Moderna, Regeneron warn about the effectiveness of COVID-19 drugs, vaccines against the omicron variant

As the world assesses the threat posed by the COVID-19 omicron variant, two top companies producing pandemic drugs and vaccines have warned that their current offerin...
1 December 2021 Regional News BioNTech | COVID-19
Continue Reading →
Regional News

AstraZeneca CEO questions mRNA vaccine superiority, raising theory that his company’s shot offers longer-lasting protection

AstraZeneca’s chief executive Pascal Soriot is challenging the notion that his company's vaccine is inferior to the mRNA vaccines from Moderna and Pfizer. In fact, h...
24 November 2021 Regional News AstraZeneca | BioNTech
Continue Reading →
Regional News

Johnson & Johnson wins FDA panel backing for a second dose of its COVID shot but don’t call it a ‘booster’

Over the last year, the Johnson & Johnson COVID-19 vaccine has been commonly referred to as a single-shot alternative to the two-dose regimens of mRNA vaccines fr...
20 October 2021 Regional News COVID-19 | FDA
Continue Reading →
Regional News

Pfizer, Moderna will rake in a combined $93 billion next year on COVID-19 vaccine sales

If you think Pfizer-BioNTech and Moderna are making a fortune on COVID-19 vaccine sales this year, just wait for 2022. The messenger RNA shot producers are projected...
20 October 2021 Regional News COVID-19 | COVID-19 vaccine
Continue Reading →
Regional News

FDA delays decision on Moderna’s COVID-19 vaccine in 12-17 age group because of myocarditis concerns

After reports in four Nordic countries of the heart inflammation condition myocarditis, the FDA has delayed a decision on the Moderna COVID-19 shot for kids between t...
20 October 2021 Regional News COVID-19 | FDA
Continue Reading →
Regional News

Researchers retract preprint study that miscalculated higher heart inflammation risk for Moderna, Pfizer COVID vaccines

In the past few weeks, anti-vaxxers have rallied behind a nonpeer-reviewed study by a group of Canadian researchers as evidence against COVID-19 vaccines. Turns out, ...
6 October 2021 Regional News COVID-19 | heart inflammation
Continue Reading →
Regional News

After Moderna contamination mess, Takeda strikes deal with Japan to supply Novavax COVID-19 vaccines

As Moderna faces questions about contaminants found in its COVID-19 vaccines in Japan, the company’s distribution partner in the country, Takeda, is moving forward on...
8 September 2021 Regional News COVID-19 | Japan
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte